Acadian Asset Management
FLNA

Acadian Asset Management’s Filana Therapeutics FLNA Stock Holding History

Acadian Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Buy
295,059
+10,846
+4% +$15.5K ﹤0.01% 1526
2026
Q1 		$478K Hold
284,213
– – ﹤0.01% 1368
2025
Q4 		$561K Buy
284,213
+259,774
+1,063% +$832K ﹤0.01% 1275
2025
Q3 		$71K Buy
+24,439
New +$56.2K ﹤0.01% 1589
2024
Q4 		– Sell
-1,746
Closed -$51K – 2093
2024
Q3 		$51K Buy
+1,746
New +$40.2K ﹤0.01% 1785
2020
Q1 		– Sell
-15,207
Closed -$79K – 1922
2019
Q4 		$79K Buy
+15,207
New +$26.3K ﹤0.01% 1530
2019
Q2 		– Sell
-39,919
Closed -$51K – 2011
2019
Q1 		$51K Buy
39,919
+16,487
+70% +$18.9K ﹤0.01% 1670
2018
Q4 		$20K Buy
+23,432
New +$26.9K ﹤0.01% 1558
2017
Q3 		– Sell
-581
Closed -$2K – 1521
2017
Q2 		$2K Buy
+581
New +$2.74K ﹤0.01% 1403
2017
Q1 		– Sell
-4,867
Closed -$19K – 1742
2016
Q4 		$19K Sell
4,867
-58,480
-92% -$271K ﹤0.01% 1322
2016
Q3 		$444K Buy
63,347
+13,194
+26% +$219K ﹤0.01% 835
2016
Q2 		$769K Buy
50,153
+353
+0.7% +$5.6K ﹤0.01% 679
2016
Q1 		$777K Sell
49,800
-419
-0.8% -$5.42K ﹤0.01% 670
2015
Q4 		$615K Sell
50,219
-445
-0.9% -$5.89K ﹤0.01% 776
2015
Q3 		$649K Sell
50,664
-964
-2% -$12.2K ﹤0.01% 740
2015
Q2 		$625K Sell
51,628
-39,494
-43% -$541K ﹤0.01% 760
2015
Q1 		$1.21M Sell
91,122
-8,628
-9% -$116K 0.01% 627
2014
Q4 		$1.42M Sell
99,750
-8,844
-8% -$153K 0.01% 567
2014
Q3 		$2.98M Buy
108,594
+15,277
+16% +$464K 0.01% 431
2014
Q2 		$3.75M Buy
93,317
+74,647
+400% +$2.76M 0.02% 422
2014
Q1 		$720K Buy
+18,670
New +$659K ﹤0.01% 620

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Acadian Asset Management's FLNA Position: Q2 2026 in Review

Acadian Asset Management increased its Filana Therapeutics (FLNA) stake by 3.8% in Q2 2026, buying an estimated $15.5K and bringing the position to 295,059 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #1526.

Acadian Asset Management first reported a position in FLNA in Q1 2014 and has held it in 21 quarters since. The position peaked at $3.75M in Q2 2014. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Acadian Asset Management held 295,059 shares of Filana Therapeutics worth $350K as of Q2 2026.
  • Acadian Asset Management bought 10,846 Filana Therapeutics shares in Q2 2026, an estimated $15.5K.
  • Filana Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1526 holding.
  • Acadian Asset Management first reported a position in Filana Therapeutics in Q1 2014 and has held it in 21 quarters since.
  • Acadian Asset Management's Filana Therapeutics position peaked at $3.75M in Q2 2014.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.